Location
United States, North America
Cheque size
$1M - $75M
Investment Stage
Seed
Series B
Focus Areas
Health IT
Health & Hospital Services
BioTech
FinTech
Pharmaceuticals
Medical Devices
About Investor
Diyong Xu is a Partner on OrbiMed’s Private Equity team, and he has been with OrbiMed since 2012. His investing focus sits within healthcare (including biotech, pharma, diagnostics, and medical devices) across private equity and growth-oriented healthcare investing. His listed investment range is $1M to $75.0M. Before OrbiMed, he was an investment banking analyst at Lazard covering healthcare transactions, and he holds graduate degrees from Stanford and Dartmouth.
Previous investments
Q32 Bio
60M |2020
46M |2020
OnCusp Therapeutics
100M |2024
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.